Want to see GENB full AI Analyst Report?
ETFs with Generate Biomedicines, Inc. (GENB) Exposure
The following ETFs maintain exposure to Generate Biomedicines, Inc. (GENB). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
34 ETFs Hold Generate Biomedicines, Inc. (GENB)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in GENB |
|---|---|---|---|---|---|---|
| HLTH | Tema Healthcare AI ETF | $12.63M | 0.75% | 2.88% | $363.62K | 0.02% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 1.24% | $2.27M | 0.12% |
| ARKG | ARK Genomic Revolution ETF | $2.37B | 0.75% | 1.06% | $23.55M | 1.27% |
| ARKG | Ark Genomic Revolution Ucits ETF AccumUSD | $123.47M | 0.79% | 1.06% | $1.46M | 0.07% |
| BBC | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | 0.91% | $312.12K | 0.02% |
| GNMX | Corgi Genomics & Precision Medicine ETF | $1.38M | 0.35% | 0.67% | $9,272.76 | <0.01% |
| TDNA | T. Rowe Price Biotech ETF | $11.32M | 0.55% | 0.29% | $33.02K | <0.01% |
| JTEK | JPMorgan U.S. Tech Leaders ETF | $4.56B | 0.65% | 0.10% | $4.57M | 0.23% |
| TNXT | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | 0.08% | $16.35K | <0.01% |
| KBFR | Innovator U.S. Small Cap Managed 10 Buffer ETF | $13.46M | 0.79% | 0.06% | $7,948.08 | <0.01% |
| RESM | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | 0.03% | $1,750.47 | <0.01% |
| VTWG | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | 0.02% | $282.26K | 0.01% |
| IWO | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | 0.02% | $2.32M | 0.12% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | 0.02% | $741.82K | 0.04% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.01% | $1,832.44 | <0.01% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | 0.01% | $9.81M | 0.48% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | 0.01% | $187.47K | <0.01% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | 0.01% | $40.91K | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.01% | $2.13M | 0.11% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | 0.01% | $21.73K | <0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | <0.01% | $2.11M | 0.10% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | <0.01% | $1.21M | 0.06% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | <0.01% | $94.62 | <0.01% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | <0.01% | $104.66K | <0.01% |
| ONEQ | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | <0.01% | $668.87K | 0.03% |
| CAUS | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | <0.01% | $27.89K | <0.01% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $4.24M | 0.22% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $473.1 | <0.01% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | <0.01% | $16.56K | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | <0.01% | $16.56K | <0.01% |
| AVUS | Avantis U.S. Equity ETF | $14.88B | 0.15% | <0.01% | $224.39K | 0.01% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $28.39M | 1.47% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $296.70K | 0.01% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $31.21K | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in GENB |
|---|---|---|---|---|---|---|
| HLTH | 2.88% | Tema Healthcare AI ETF | $12.63M | 0.75% | $363.62K | 0.02% |
| SBIO | 1.24% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $2.27M | 0.12% |
| ARKG | 1.06% | ARK Genomic Revolution ETF | $2.37B | 0.75% | $23.55M | 1.27% |
| ARKG | 1.06% | Ark Genomic Revolution Ucits ETF AccumUSD | $123.47M | 0.79% | $1.46M | 0.07% |
| BBC | 0.91% | Virtus LifeSci Biotech Clinical Trials ETF | $35.24M | 0.65% | $312.12K | 0.02% |
| GNMX | 0.67% | Corgi Genomics & Precision Medicine ETF | $1.38M | 0.35% | $9,272.76 | <0.01% |
| TDNA | 0.29% | T. Rowe Price Biotech ETF | $11.32M | 0.55% | $33.02K | <0.01% |
| JTEK | 0.10% | JPMorgan U.S. Tech Leaders ETF | $4.56B | 0.65% | $4.57M | 0.23% |
| TNXT | 0.08% | T. Rowe Price Innovation Leaders ETF | $19.28M | 0.49% | $16.35K | <0.01% |
| KBFR | 0.06% | Innovator U.S. Small Cap Managed 10 Buffer ETF | $13.46M | 0.79% | $7,948.08 | <0.01% |
| RESM | 0.03% | Columbia Research Enhanced Small Cap ETF | $5.96M | 0.32% | $1,750.47 | <0.01% |
| VTWG | 0.02% | Vanguard Russell 2000 Growth ETF | $1.44B | 0.06% | $282.26K | 0.01% |
| IWO | 0.02% | iShares Russell 2000 Growth ETF | $14.31B | 0.24% | $2.32M | 0.12% |
| R2EH | 0.02% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $741.82K | 0.04% |
| VRSD | 0.01% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $1,832.44 | <0.01% |
| IWM | 0.01% | iShares Russell 2000 ETF | $76.76B | 0.19% | $9.81M | 0.48% |
| RSSL | 0.01% | Global X Russell 2000 ETF | $1.47B | 0.08% | $187.47K | <0.01% |
| RTYS | 0.01% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $40.91K | <0.01% |
| VTWO | 0.01% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $2.13M | 0.11% |
| ITWO | 0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $21.73K | <0.01% |
| SCHA | <0.01% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $2.11M | 0.10% |
| IWN | <0.01% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $1.21M | 0.06% |
| RB | <0.01% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $94.62 | <0.01% |
| VTWV | <0.01% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $104.66K | <0.01% |
| ONEQ | <0.01% | Fidelity Nasdaq Composite Index ETF | $10.76B | 0.21% | $668.87K | 0.03% |
| CAUS | <0.01% | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | $27.89K | <0.01% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $4.24M | 0.22% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $473.1 | <0.01% |
| AVGC | <0.01% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $16.56K | <0.01% |
| AVUS | <0.01% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $16.56K | <0.01% |
| AVUS | <0.01% | Avantis U.S. Equity ETF | $14.88B | 0.15% | $224.39K | 0.01% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $28.39M | 1.47% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $296.70K | 0.01% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $31.21K | <0.01% |
Popular ETF Comparisons
GENB ETF Exposure FAQ
What ETFs hold Generate Biomedicines, Inc. stock?
Generate Biomedicines, Inc. (GENB) is currently held by 34 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to GENB include ARK (ARKG), JPMorgan (JTEK) and ALPS (SBIO).
Which ETF has the largest exposure to GENB?
The ETF with the largest exposure to GENB is ARK (ARKG), with approximately $23.55M in market value exposure.
How much GENB stock is held by ETFs?
ETFs currently hold approximately $32.59M worth of Generate Biomedicines, Inc. (GENB) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.